Lucknow, India

Preeti Chand

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Preeti Chand. Retrieved from https://idiyas.com/inventor/preeti-chand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Preeti Chand - Innovator in Alpha-Arteether Resistance

Introduction

Preeti Chand is a notable inventor based in Lucknow, India. She has made significant contributions to the field of medical research, particularly in the area of drug resistance.

Latest Patents

Her most recent patent is titled "Alpha Arteether Resistance Domain." This invention relates to an alpha-arteether resistance domain (ADR) of Sequence ID No.1. It also includes a method for identifying ADR in alpha-arteether resistant pathogens. Additionally, the patent features three pairs of primers of sequence ID Nos. 3 to 8.

Career Highlights

Preeti Chand is affiliated with the Council of Scientific & Industrial Research, where she conducts her research and development activities. Her work focuses on addressing critical challenges in the medical field, particularly concerning drug resistance.

Collaborations

She collaborates with esteemed colleagues such as Suman Preet Singh Khanuja and Suchi Srivastava, contributing to a dynamic research environment.

Conclusion

Preeti Chand's innovative work in the realm of alpha-arteether resistance showcases her dedication to advancing medical science. Her contributions are vital in the ongoing battle against drug-resistant pathogens.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…